Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$8.57 - $12.69 $146,281 - $216,605
-17,069 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$15.58 - $20.01 $1.05 Million - $1.34 Million
-67,135 Reduced 79.73%
17,069 $268,000
Q4 2018

Feb 14, 2019

BUY
$14.59 - $23.84 $652,012 - $1.07 Million
44,689 Added 113.09%
84,204 $1.3 Million
Q3 2018

Nov 14, 2018

SELL
$21.06 - $25.65 $127,223 - $154,951
-6,041 Reduced 13.26%
39,515 $851,000
Q2 2018

Aug 14, 2018

SELL
$16.77 - $24.71 $109,524 - $161,381
-6,531 Reduced 12.54%
45,556 $1.11 Million
Q1 2018

May 15, 2018

BUY
$16.68 - $22.07 $868,811 - $1.15 Million
52,087 New
52,087 $890,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $25.3B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Lombard Odier Asset Management (Switzerland) Sa Portfolio

Follow Lombard Odier Asset Management (Switzerland) Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.